Loading...
XTAI
1736
Market cap1.24bUSD
Jul 09, Last price  
131.50TWD
1D
-0.38%
1Q
8.68%
Jan 2017
183.10%
IPO
587.76%
Name

Johnson Health Tech Co Ltd

Chart & Performance

D1W1MN
XTAI:1736 chart
P/E
14.51
P/S
0.73
EPS
9.06
Div Yield, %
3.04%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
13.88%
Revenues
54.33b
+13.69%
11,321,209,00011,809,140,00012,051,444,00010,089,365,00011,749,608,00013,634,144,00015,320,890,00015,071,154,00016,551,036,00016,974,930,00020,164,515,00019,494,431,00021,757,064,00025,372,561,00028,366,756,00030,779,328,00033,612,947,00038,069,563,00047,785,398,00054,328,964,000
Net income
2.75b
+13.16%
1,706,627,000560,266,0002,259,000-65,526,000250,686,000770,689,000857,357,000856,968,0002,637,700,000563,605,000716,180,000130,176,000389,787,0001,292,531,000679,293,00099,369,000224,941,000709,828,0002,430,180,0002,750,086,000
CFO
2.58b
+144.59%
1,472,945,000603,870,000-351,876,0001,241,438,000342,556,000316,046,000275,715,000771,342,0001,850,987,000-217,060,0001,255,456,000-73,707,000980,671,000943,231,0002,941,790,000-3,537,026,000392,453,0003,842,551,0001,053,553,0002,576,866,000
Dividend
Jul 31, 20254 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Johnson Health Tech. Co., Ltd. is a prominent global supplier specializing in the production and distribution of health and fitness equipment. Their diverse product lineup includes a wide array of cardiovascular and strength training machines, alongside integrated electronic components and a dedicated video streaming service. Operating worldwide, the company serves key markets across the Americas, Europe, and Asia, with a notable presence in China. Beyond their core fitness offerings, Johnson Health Tech also researches, develops, and markets therapeutic massage chairs, and provides a selection of food products. The enterprise was founded in 1975 and is headquartered in Taichung City, Taiwan.
URL
https://www.johnsonfitness.com/
IPO date
Jul 11, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT